CADEX GENOMICS
"CADEX GENOMICS" is a word mark owned by Cadex Genomics, Corp., filed at the USPTO on February 11, 2019. It is registered and covers classes 5, 42 and 44.
- Status
- Registered
- Since September 22, 2020
- Filed
- February 11, 2019
- Registered
- September 22, 2020
- Expires
- Not recorded
- Application no.
- 88296676
- Registration no.
- 6159028
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 3 classes
Who owns CADEX GENOMICS
The owner and representative on file with the office.
Owner
Cadex Genomics, Corp.
Redwood City, United States
Representative
James K. Stronski
Crowell & Moring LLP
What the mark covers
The products and services CADEX GENOMICS is filed for, grouped by Nice class.
Medical diagnostic assays for testing of bodily fluids, namely, assays used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy; Medical diagnostic test media in the form of reagents used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy; medical diagnostic kits comprised of medical diagnostic reagents and assays used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy
Medical and scientific research in the field of medical diagnostic assays and clinical testing services for the purpose of testing of bodily fluids used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy; Research and development in the pharmaceutical and biotechnology fields, namely, research and development in the development of testing and information services related to medical diagnostic assays and clinical tests, and medical diagnostic kits used to conduct medical diagnostic assays and clinical tests
Medical testing for diagnostic or treatment purposes, namely, for the purpose of testing of bodily fluids used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy
What has happened so far
Steps recorded by the USPTO, newest first.
- Courtesy reminder - sec. 8 (6-yr) e-mailed
- Registered-principal register
- Notice of acceptance of statement of use e-mailed
- Allowed principal register - sou accepted
- Statement of use processing complete
- Case assigned to intent to use paralegal
- Use amendment filed
- Teas statement of use received
- Noa e-mailed - sou required from applicant
- Official gazette publication confirmation e-mailed
10 earlier steps on the official record.
About CADEX GENOMICS
Who owns the trademark "CADEX GENOMICS"?
The USPTO trademark "CADEX GENOMICS" (application 88296676) is owned by Cadex Genomics, Corp.
What is the status of "CADEX GENOMICS"?
Its status at the USPTO is: registered.
When was "CADEX GENOMICS" registered?
It was registered on September 22, 2020.
Get this data via the API
Everything on this page comes from the Signa API. Pull CADEX GENOMICS and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2a3b-8580-737d-8737-d9012a48b59d
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2a3b-8580-737d-8737-d9012a48b59d",
"object": "trademark",
"mark_text": "CADEX GENOMICS",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "US",
"application_number": "88296676",
"filing_date": "2019-02-11",
"nice_classes": [
5,
42,
44
],
"owners": [
{
"name": "Cadex Genomics, Corp.",
"entity_id": null
}
]
}